News from ani pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 04, 2014, 08:30 ET

ANI Reports Second Quarter 2014 Financial Results and Year-To-Date Highlights

 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported financial results for the three and six months ended June 30, 2014 and...

Aug 01, 2014, 16:30 ET

ANI Pharmaceuticals Acquires Vancocin® Capsules and Additional Vancomycin Assets from Shire

 ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) today announced that it has acquired the US rights for Vancocin® 125 mg and 250 mg capsules...

Jul 28, 2014, 08:30 ET

ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results

 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its second quarter and year-to-date 2014 financial...

Jul 01, 2014, 10:50 ET

ANI Pharmaceuticals Acquires Lithobid® Extended Release Tablets from Noven Therapeutics

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) today announced that it has acquired the NDA for Lithobid® (lithium carbonate extended release 300 mg...

Jun 18, 2014, 08:30 ET

ANI Pharmaceuticals Signs Exclusive License and Supply Agreement with Dexcel Pharma Technologies Ltd.

 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has signed an exclusive license and supply agreement with Dexcel Pharma Technologies Ltd. ("Dexcel")...

May 05, 2014, 08:30 ET

ANI Pharmaceuticals Reports Record Net Revenues of $10.9 million, EPS of $0.33, and Adjusted Non-GAAP EBITDA of $4.2 Million for the First Quarter Ended March 31, 2014

 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported financial results for the three months ended March 31, 2014. First quarter...

May 01, 2014, 09:00 ET

ANI Pharmaceuticals Expands Product Development Collaboration with Sofgen

 ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) announced today that it has signed an exclusive licensing, development and supply agreement...

Apr 28, 2014, 08:30 ET

ANI Pharmaceuticals Schedules Conference Call for First Quarter 2014 Financial Results

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its first quarter 2014 financial results on Monday, May...

Mar 10, 2014, 17:00 ET

ANI Pharmaceuticals Presents at 26th Annual ROTH Conference

 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) presented at the 26th Annual ROTH Conference at the Ritz-Carlton at Laguna Niguel, California. On...

Mar 10, 2014, 10:45 ET

ANI Pharmaceuticals Announces Closing Of Public Offering Of Common Stock

ANI Pharmaceuticals, Inc. (the "Company") (NASDAQ: ANIP), today announced the closing of its previously announced underwritten public offering of...

Mar 10, 2014, 08:00 ET

ANI Pharmaceuticals Expands Generic Drug Development Agreement with Sterling Pharmaceuticals

 ANI Pharmaceuticals, (NASDAQ: ANIP), an emerging generic pharmaceutical company, today announced that it has entered into a fee for service...

Mar 06, 2014, 10:45 ET

ANI Pharmaceuticals to Present at 26th Annual ROTH Conference

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that its President and Chief Executive Officer, Arthur S. Przybyl, is scheduled to present...

Mar 05, 2014, 09:00 ET

ANI Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock

 ANI Pharmaceuticals, Inc. (the "Company") (NASDAQ: ANIP) today announced that it has priced a firm commitment underwritten public...

Mar 04, 2014, 16:50 ET

ANI Pharmaceuticals Announces Proposed Public Offering Of Common Stock

 ANI Pharmaceuticals, Inc. (the "Company") (NASDAQ:  ANIP) today announced that it intends to offer its common stock in a registered...

Feb 18, 2014, 08:30 ET

ANI Pharmaceuticals Reports Record Net Revenues of $10.5 million, EPS from continuing operations of $0.35, and Adjusted Non-GAAP EBITDA of $3.9 Million for the Fourth Quarter Ended December 31, 2013

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported financial results for the three and twelve months ended December 31, 2013. Fourth...

Feb 06, 2014, 08:00 ET

ANI Pharmaceuticals Schedules Conference Call for Fourth Quarter and Full Year 2013 Financial Results

 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its fourth quarter and full year 2013 financial...

Jan 06, 2014, 08:00 ET

ANI Pharmaceuticals Enters Development Agreement for Generic Drug Product with Sterling Pharmaceutical Services

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), an emerging generic pharmaceutical company, today announced that it has entered into a...

Dec 26, 2013, 16:30 ET

ANI Pharmaceuticals Acquires 31 Generic Drug Products from Teva Pharmaceuticals

 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), an emerging generic pharmaceutical company, today announced that it has acquired 31 previously...

Dec 10, 2013, 20:00 ET

ANI Pharmaceuticals Presents At Oppenheimer 24th Annual Healthcare Conference

 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) presented at the Oppenheimer & Co. 24th Annual Healthcare Conference at the Crowne Plaza Hotel in...

Nov 15, 2013, 08:00 ET

ANI Pharmaceuticals To Present At Oppenheimer 24th Annual Healthcare Conference On December 10, 2013

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will be presenting at the Oppenheimer & Co. 24th Annual Healthcare Conference.  The Conference...